ANTG is a proudly Australian, independently owned medicinal cannabis focused company.
We are motivated by the possibilities and health benefits that medicinal cannabis offers.
We combine a strong research focus with best in class cultivation and extraction systems to produce exclusive high quality cannabinoid-based medical treatments that can meet individual patient needs.
“Our pioneering approach is underpinned by deep expertise and a commitment to reduce suffering and improve people’s lives through the research, development and clinical application of cannabinoid-based medical treatments”
MATT CANTELO, ANTG CHIEF EXECUTIVE OFFICER.
Our CEO and founder, Matt Cantelo has met with the business editor at The Sydney Morning Herald to discuss the future of medicinal cannabis in Australia, ANTG’s export plans and company’s current investments into research.
A story of six year old Cooper who has been diagnosed with Epilepsy two years ago. After trying a range of traditional medications over the years with very little success, Cooper’s parents decided to start on medicinal product to help him with seizures that have eventually stopped.
To help Australian patients easily access the best quality medicinal cannabis, Greg Hunt, the health minister has launched Medicinal Cannabis Industry Australia. The role of this newly created industry body will be to ensure that medicinal cannabis products achieve the highest standards to meet patients’ individual needs.
Our CEO and founder, Matt Cantelo has recently met with the editor of the local newspaper, The Northern Daily Leader to discuss ANTG’s partnership with Cannamedical Pharma, German pharmaceutical company and its plans for growth, including the opening of their new facility in Armidale.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.
LEARN ABOUT ANTG HERE >
